Literature DB >> 24792331

Molecular cloning and expression analysis of pig CD7.

Ju Yeon Lee1, Joonbeom Bae, Inho Choi, Chung-Gyu Park, Taehoon Chun.   

Abstract

CD7 is an integral membrane protein which mediates an important signal to mediate the differentiation, activation, and regulation of some T cells and NK cells. However, only human and mouse CD7 have been identified and studied among mammalian species. In this study, we cloned pig CD7 cDNA and determined its complete cDNA sequence. Pig CD7 cDNA contained an open reading frame (627 bp) encoding 208 amino acids with well conserved motifs involved in signal transduction within cytoplasmic tail among mammalian species. Pig CD7 mRNA was detected by RT-PCR in mainly lymphoid tissues, indicating the conserved functions of CD7 in pigs. Moreover, we generated soluble pig CD7 fusion immunoglobulin (pig CD7Ig) containing extracellular domain of pig CD7 to test whether pig CD7 binds to pig galectin-3. Flow cytometry and immunohistochemistry analyses indicated that soluble pig CD7Ig can bind to galectin-3 expressed in macrophages and epithelial cells of small intestine. These results help to analyze the structural relationship between CD7 and its ligand transferring signal transduction among mammalian species.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792331     DOI: 10.1007/s11259-014-9603-4

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  22 in total

1.  Association of T cell antigen CD7 with type II phosphatidylinositol-4 kinase, a key component in pathways of inositol phosphate turnover.

Authors:  Gosukonda Subrahmanyam; Christopher E Rudd; Helga Schneider
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

2.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1.

Authors:  K E Pace; C Lee; P L Stewart; L G Baum
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

3.  Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif.

Authors:  D M Lee; D D Patel; A M Pendergast; B F Haynes
Journal:  Int Immunol       Date:  1996-08       Impact factor: 4.823

4.  Inhibition of alloresponsive naive and memory T cells by CD7 and CD25 antibodies and by cyclosporine.

Authors:  A N Akbar; P L Amlot; K Ivory; A Timms; G Janossy
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

5.  Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells.

Authors:  S Carrel; S Salvi; F Rafti; M Favrot; C Rapin; R P Sekaly
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

6.  Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.

Authors:  B F Haynes; G S Eisenbarth; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Molecular cloning and expression analysis of pig lymphocyte activation gene-3 (LAG-3; CD223).

Authors:  Seon-Soo Kim; Sang-Hoon Kim; Hyung-Sik Kang; Hee Yong Chung; Inho Choi; Yong-Pil Cheon; Ki Ho Lee; Dong-Mok Lee; Jongsun Park; Sang Yeol Lee; Taehoon Chun
Journal:  Vet Immunol Immunopathol       Date:  2009-07-10       Impact factor: 2.046

8.  CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.

Authors:  Gregory D Sempowski; Scott J Cross; Craig S Heinly; Richard M Scearce; Barton F Haynes
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

9.  Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.

Authors:  H Rabinowich; W C Lin; R B Herberman; T L Whiteside
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

10.  Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes.

Authors:  G D Sempowski; D M Lee; R M Scearce; D D Patel; B F Haynes
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.